The two main types of acute leukemia are acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). Each can cause symptoms over days or weeks, including: Chronic leukemia causes problems in ...

The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). A research team from Columbia Engineering and ...

Acute myeloid leukemia (AML) is one of the most common hematologic malignancies that is characterized by clonal expansion of abnormally differentiated myeloid blasts (1, 2). High treatment failure ...

The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...

Myelodysplasticsyndrome (MDS) and acute myeloid leukemia (AML) are clonal hematopoietic stem cell diseases leading to ... However, markers of iron overload are in many ways subject to the ...

Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

Patients with high-risk AML, that is, megakaryoblastic leukemia (M7), RAEB-T, secondary AML, -7, 5q-, t(9;22) or persistent leukemia after DAV 1, were eligible for allogeneic hematopoietic stem ...

The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome prior to alloHSCT ... OS, defined as the time from randomization until ...

in acute myeloid leukemia (AML). Following this interim analysis triggered by 60 events (deaths) in the study population, the IDMC has recommended that the trial continue without modifications.

According to the American Cancer Society, rates of leukemia — particularly acute myeloid leukemia — are ... Researchers aren’t exactly sure what causes CLL. A combination of genetic and ...